Global Infection Control Market to Grow at 6.5% During 2024-2032, Catalyzed by Increasing Incidences of Nosocomial Infections

According to the latest report by IMARC Group, titled "Infection Control Market Report by Type (Equipment, Services, Consumables), End User (Hospitals and Clinics, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, and Others), and Region 2024-2032," the global infection control market reached a value of US$ 26.4 Billion in 2023. Infection control refers to the scientific approach and practical solutions that aim to avert or control the spread of infections in healthcare settings. Numerous hospitals, clinics and laboratories use these solutions to ensure the safety of patients and healthcare workers by preventing their exposure to pathogens, including viruses, bacteria, parasites and fungi. These pathogens can commonly cause ear, eye, skin, urinary tract, lung and respiratory, stomach and intestinal, and sexually transmitted infections (STIs) among individuals through contact, sprays and splashes, inhalation, and sharps injuries. As a result, certain standard procedures are maintained by healthcare professionals to ensure patient and employee safety. Some of these practices include standard immunizations, cleaning, disinfecting and sterilizing objects and surfaces, and mandatory usage of protective clothing, including gloves, masks and surgical drapes and gowns.

Global Infection Control Market Trends:

The market is primarily driven by the increasing incidences of nosocomial infections on the global level. This can be attributed to rising hospital admissions, along with the increasing number of surgical procedures that make patients prone to infections. This, coupled with the increasing health consciousness among the masses, has impelled healthcare professionals to ensure strict implementation of infection control measures. The market is also driven by a considerable rise in the elderly population across the globe. Since the geriatric population is more prone to develop hospital-acquired infections (HAI), there has been a significant rise in the demand for infection control solutions. The market is further driven by the growing emphasis on food sterilization and disinfection for reducing the risks of contamination. Moreover, numerous government and non-government organizations (NGOs) are undertaking initiatives to spread awareness regarding the need for disinfection and maintenance of proper hygiene in the healthcare sector. This, along with technological advancements in sterilization equipment and the increasing preference for outsourcing sterilization services, is expected to create a positive outlook for the market. Furthermore, on account of the rapid spread of the coronavirus disease (COVID-19) across the globe, the World Health Organization (WHO) has issued guidelines for the prevention and control of acute respiratory diseases that includes detailed instructions pertaining to standard infection control precautions, such as disinfection and sterilization, across healthcare settings. This, in turn, is significantly boosting the uptake for masks, personal protection equipment (PPE) and sanitizers, thus contributing to the market growth. Some of the other growth-inducing factors include the launch of single-use medical nonwoven devices and the easy availability of sanitizers with high-intensity infection prevention capabilities. Looking forward, the market is expected to grow at a CAGR of 6.5% during 2024-2032.

Market Summary:

• On the basis of the type, the market has been divided into equipment (disinfectors, sterilization equipment and others), services (contract sterilization and infectious waste disposal) and consumables (disinfectants, sterilization consumables, personal protective equipment, and others).
• Based on the end user, the market has been classified into hospitals and clinics, medical device companies, clinical laboratories, pharmaceutical companies, and others.
• On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
• The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include 3M Company, Advanced Sterlization Products Services Inc. (Fortive Corporation), Belimed AG (Metall Zug), Cantel Medical Corp., Getinge AB, Matachana, Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.), MMM Münchener Medizin Mechanik GmbH, Pal International, Sterigenics U.S. LLC (Sotera Health Holdings LLC), Steris Corporation and TSO3 Inc. (Stryker Corporation).

Report Coverage:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800